This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Vorbach, E.-U. Articles by Arnoldt, K.-H. Search for Related Content PubMed PubMed Citation Articles by Vorbach, E.-U. Articles by Arnoldt, K.-H. Social Bookmarking                         What's this?

Effectiveness and Tolerance of the Hypericum Extract LI 160 in Comparison with Imipramine: Randomized Double-Blind Study with 135 Outpatients

W.-D. Hübner

K.-H. Arnoldt

In a double-blind comparative study, 135 depressed patients were treated in 20 centers. Inclusion diagnoses were typical depressions with single episode (296.2), several episodes (296.3), depressive neurosis (300.4), and adjustment disorder with depressed mood (309.0) in accordance with DSM-III-R. The dosage was 3 x 300 mg hypericum extract LI 160 or 3 x 25 mg imipramine daily. The treatment lasted for 6 weeks. Main assessment criteria were the Hamilton Depression Scale (HAMD), the Depression Scale according to von Zerssen (D-S) and the Clinical Global Impressions (CGI). In both treatment groups, a parallel reduction of the Hamilton score from 20.2 to 8.8 (LI 160, n = 67) or from 19.4 to 10.7 (imipramine, n = 68), and the transformed D-S point values from 39.6 to 27.2 (LI 160) and 39.0 to 29.2 (imipramine) were found. The analysis of CGI revealed comparable results in both treatment groups. Clinically relevant changes of the safety parameters were not found. In the LI 160 group fewer and milder side effects were found as compared to imipramine. (J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S19-S23).

Journal of Geriatric Psychiatry and Neurology, Vol. 7, No. 1, S19-S23 (1994)
DOI: 10.1177/089198879400700107


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A Szegedi, R Kohnen, A Dienel, and M Kieser Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine BMJ, March 5, 2005; 330(7490): 503. [Abstract] [Full Text] [PDF]

				K. LINDE, M. BERNER, M. EGGER, and C. MULROW St John's wort for depression: Meta-analysis of randomised controlled trials The British Journal of Psychiatry, February 1, 2005; 186(2): 99 - 107. [Abstract] [Full Text] [PDF]

				Final Report on the Safety Assessment of Hypericum Perforatum Extract and Hypericum Perforatum Oil International Journal of Toxicology, January 1, 2001; 20(2_suppl): 31 - 39. [Abstract] [PDF]

				J. W. Williams Jr., C. D. Mulrow, E. Chiquette, P. H. Noel, C. Aguilar, and J. Cornell A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2 Ann Intern Med, May 2, 2000; 132(9): 743 - 756. [Abstract] [Full Text] [PDF]

				G. Harrer and V. Schulz Clinical Investigation of the Antidepressant Effectiveness of Hypericum J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S6 - S8. [Abstract] [PDF]

				H. Sommer and G. Harrer Placebo-Controlled Double-Blind Study Examining the Effectiveness of an Hypericum Preparation in 105 Mildly Depressed Patients J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S9 - S11. [Abstract] [PDF]

				W.-D. Hubner, S. Lande, and H. Podzuweit Hypericum Treatment of Mild Depressions with Somatic Symptoms J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S12 - S14. [Abstract] [PDF]

				G. Harrer, W.-D. Hubner, and H. Podzuweit Effectiveness and Tolerance of the Hypericum Extract LI 160 Compared to Maprotiline: A Multicenter Double-Blind Study J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S24 - S28. [Abstract] [PDF]

				H. Woelk, G. Burkard, and J. Grunwald Benefits and Risks of the Hypericum Extract LI 160: Drug Monitoring Study with 3250 Patients J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S34 - S38. [Abstract] [PDF]

				H. Schulz and M. Jobert Effects of Hypericum Extract on the Sleep EEG in Older Volunteers J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S39 - S43. [Abstract] [PDF]

				B. Staffeldt, R. Kerb, J. Brockmoller, M. Ploch, and I. Roots Pharmacokinetics of Hypericin and Pseudohypericin After Oral Intake of the Hypericum Perforatum Extract LI 160 in Healthy Volunteers J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S47 - S53. [Abstract] [PDF]

				H. Wagner and S. Bladt Pharmaceutical Quality of Hypericum Extracts J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S65 - S68. [Abstract] [PDF]